BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24904671)

  • 1. Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy.
    Kasznicki J
    Arch Med Sci; 2014 May; 10(2):345-54. PubMed ID: 24904671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of high-dose intramuscular vitamin D
    Chen T; Xing X; Huang L; Tu M; Lai X; Wen S; Cai J; Lin S; Zheng Y; Lin Y; Xu L; Qiu Y; Qiu L; Xu Y; Wu P
    Front Endocrinol (Lausanne); 2023; 14():1202917. PubMed ID: 37484958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
    Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
    Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older subjects with diabetes and prediabetes are frequently unaware of having distal sensorimotor polyneuropathy: the KORA F4 study.
    Bongaerts BW; Rathmann W; Heier M; Kowall B; Herder C; Stöckl D; Meisinger C; Ziegler D
    Diabetes Care; 2013 May; 36(5):1141-6. PubMed ID: 23275355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts in the management of diabetic polyneuropathy.
    Ziegler D; Papanas N; Schnell O; Nguyen BDT; Nguyen KT; Kulkantrakorn K; Deerochanawong C
    J Diabetes Investig; 2021 Apr; 12(4):464-475. PubMed ID: 32918837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative thermal testing as a screening and follow-up tool for diabetic sensorimotor polyneuropathy in patients with type 2 diabetes and prediabetes.
    Huang YC; Chuang YC; Chiu WC; Huang CC; Cheng BC; Kuo CA; Lin TY; Chiang HC; Lai YR
    Front Neurosci; 2023; 17():1115242. PubMed ID: 37051142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetic polyneuropathy].
    Ziegler D
    Internist (Berl); 2020 Mar; 61(3):243-253. PubMed ID: 32086529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal confocal microscopy as a non-invasive test to assess diabetic peripheral neuropathy.
    Xiong Q; Lu B; Ye HY; Liu SY; Zheng HP; Zhang RY; Qiao XN; Zhang S; Liu XX; Li QC; Yi N; Wu LC; Wen J; Zhang TS; Li YM
    Diabetes Res Clin Pract; 2018 Feb; 136():85-92. PubMed ID: 29221815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations.
    Haque F; Ibne Reaz MB; Chowdhury MEH; Md Ali SH; Ashrif A Bakar A; Rahman T; Kobashi S; Dhawale CA; Sobhan Bhuiyan MA
    Comput Biol Med; 2021 Dec; 139():104954. PubMed ID: 34715551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    J Diabetes Investig; 2024 Feb; 15(2):247-253. PubMed ID: 38213265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Diabetic Distal Symmetric Polyneuropathy on the Performance of the Musculoskeletal System of Lower Leg and Foot.
    Bursac SN; Jandric S; Talic G
    Med Arch; 2019 Aug; 73(4):262-267. PubMed ID: 31762562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations.
    Ziegler D; Tesfaye S; Spallone V; Gurieva I; Al Kaabi J; Mankovsky B; Martinka E; Radulian G; Nguyen KT; Stirban AO; Tankova T; Varkonyi T; Freeman R; Kempler P; Boulton AJ
    Diabetes Res Clin Pract; 2022 Apr; 186():109063. PubMed ID: 34547367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Sensorimotor Polyneuropathy: An Overview on Epidemiology, Risk Factors, Classification, Diagnosis, and Treatment.
    Anastasiou G; Liberopoulos E; Tentolouris N; Papanas N
    Int J Low Extrem Wounds; 2024 Mar; ():15347346241240513. PubMed ID: 38533581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: the Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10).
    Kamiya H; Himeno T; Watarai A; Baba M; Nishimura R; Tajima N; Nakamura J
    Diabetol Int; 2024 Jan; 15(1):19-27. PubMed ID: 38264223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between distal symmetric polyneuropathy in diabetes with all-cause mortality - a meta-analysis.
    Vági OE; Svébis MM; Domján BA; Körei AE; Tesfaye S; Horváth VJ; Kempler P; Tabák ÁG
    Front Endocrinol (Lausanne); 2023; 14():1079009. PubMed ID: 36875485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).
    Sharma S; Rayman G
    Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Management of Diabetic Neuropathy.
    Ang L; Cowdin N; Mizokami-Stout K; Pop-Busui R
    Diabetes Spectr; 2018 Aug; 31(3):224-233. PubMed ID: 30140138
    [No Abstract]   [Full Text] [Related]  

  • 20. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.